Your browser doesn't support javascript.
COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management.
Sattar, Yasar; Ullah, Waqas; Rauf, Hiba; Virk, Hafeez Ul Hassan; Yadav, Sunita; Chowdhury, Medhat; Connerney, Michael; Mamtani, Sahil; Pahuja, Mohit; Patel, Raj D; Mir, Tanveer; Almas, Talal; Moussa Pacha, Homam; Chadi Alraies, M.
  • Sattar Y; Internal Medicine, Icahn School of Medicine at Mount Sinai - Elmhurst Hospital, NY, USA.
  • Ullah W; Internal Medicine, Abington Jefferson Health, PA, USA.
  • Rauf H; Internal Medicine, American Society of Clinical Oncology, VA, USA.
  • Virk HUH; Interventional Cardiology, Case Western Reserve University/University Hospitals, Cleveland Medical Center, Cleveland, OH, USA.
  • Yadav S; Internal Medicine, Jacobi Medical Center, 1400 Pelham Parkway South, Bronx, NY, USA.
  • Chowdhury M; Internal Medicine, Rochester General Hospital, Rochester, NY, USA.
  • Connerney M; Internal Medicine, Icahn School of Medicine at Mount Sinai - Elmhurst Hospital, NY, USA.
  • Mamtani S; Internal Medicine, Jacobi Medical Center, 1400 Pelham Parkway South, Bronx, NY, USA.
  • Pahuja M; Internal Medicine, Rochester General Hospital, Rochester, NY, USA.
  • Patel RD; Detroit Medical Center, Wayne State University, Detroit, MI, USA.
  • Mir T; Detroit Medical Center, Wayne State University, Detroit, MI, USA.
  • Almas T; University of Illinois College of Medicine Peoria, Chicago, IL, USA.
  • Moussa Pacha H; Detroit Medical Center, Wayne State University, Detroit, MI, USA.
  • Chadi Alraies M; Internal Medicine, Detroit Medical Center, Wayne State University, Detroit, MI, USA.
Int J Cardiol Heart Vasc ; 29: 100589, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-642152
ABSTRACT
Coronavirus Disease 2019 (COVID-19) is a rapidly progressing global pandemic that may present with a variety of cardiac manifestations including, but not limited to, myocardial injury, myocardial infarction, arrhythmias, heart failure, cardiomyopathy, shock, thromboembolism, and cardiac arrest. These cardiovascular effects are worse in patients who have pre-existing cardiac conditions such as coronary artery disease, hypertension, diabetes mellitus, and coagulation abnormalities. Other predisposing risk factors include advanced age, immunocompromised state, and underlying systemic inflammatory conditions. Here we review the cellular pathophysiology, clinical manifestations and treatment modalities of the cardiac manifestations seen in patients with COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Int J Cardiol Heart Vasc Year: 2020 Document Type: Article Affiliation country: J.ijcha.2020.100589

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Int J Cardiol Heart Vasc Year: 2020 Document Type: Article Affiliation country: J.ijcha.2020.100589